Aclaris Therapeutics, Inc. (ACRS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 02:30PM EDT. Market open.
| Previous Close | 1.2000 |
| Open | 1.1900 |
| Bid | 1.1600 x 100 |
| Ask | 1.1700 x 100 |
| Day's Range | 1.1600 - 1.1900 |
| 52 Week Range | 0.5900 - 5.7050 |
| Volume | |
| Avg. Volume | 457,343 |
| Market Cap | 82.76M |
| Beta (5Y Monthly) | 0.22 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GuruFocus.com
Millennium Management LLC Reduces Stake in Aclaris Therapeutics Inc
On September 30, 2024, Millennium Management LLC, a prominent hedge fund, executed a significant transaction involving the shares of Aclaris Therapeutics Inc (NASDAQ:ACRS). The firm reduced its holdings by 331,252 shares, resulting in a new total of 3,005,598 shares in the biopharmaceutical company. This move reflects a strategic adjustment in Millenniums investment portfolio, with the shares priced at $1.15 during the transaction.
- Zacks
Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year?
Here is how BellRing Brands (BRBR) and Aclaris Therapeutics (ACRS) have performed compared to their sector so far this year.
- Simply Wall St.
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
A week ago, Aclaris Therapeutics, Inc. ( NASDAQ:ACRS ) came out with a strong set of second-quarter numbers that could...
© 2024 Yahoo. All rights reserved.